{"nctId":"NCT00282464","briefTitle":"A Six-week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression.","startDateStruct":{"date":"2006-02"},"conditions":["Bipolar Disorder"],"count":392,"armGroups":[{"label":"Ziprasidone 20 and 60mg","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Geodon (Ziprasidone)"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Placebo","otherNames":[]},{"name":"Geodon (Ziprasidone)","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects must have a primary diagnosis of Bipolar I Disorder, most recent episode depressed, with or without rapid cycling, without psychotic features, as defined in DSM-IV-TR (296.5X) and confirmed by a structured Mini International Neuropsychiatric Interview (MINI)\n\nExclusion Criteria:\n\n* Subjects with a DSM-IV TR diagnosis of schizophrenia (295.XX), schizoaffective disorder (295.70), schizophreniform disorder (295.40), delusional disorder (297.1), or psychotic disorder NOS (298.9).\n* Subjects with other DSM-IV TR Axis I or Axis II disorder (in addition to Bipolar I disorder) are ineligible if the comorbid condition is clinically unstable, requires treatment, or has been a primary focus of treatment within the 6 month period prior to screening.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"SECONDARY","title":"Response Greater Than or Equal to 50 Percent Decrease From Baseline in Montgomery-Asberg Rating Scale (MADRS) Total Score","description":"Participants with MADRS Total Score greater than or equal to 50 percent decrease from baseline responded yes; others responded no. MADRS: 10-item instrument measuring depression; scale 0(Normal) \\& 6 (most abnormal)for each item. Total possible score is 0 - 60. Endpoint is last observation carried forward (LOCF)","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"40","spread":null},{"groupId":"OG001","value":"24","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"137","spread":null},{"groupId":"OG001","value":"168","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"55","spread":null},{"groupId":"OG001","value":"48","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"105","spread":null},{"groupId":"OG001","value":"128","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"71","spread":null},{"groupId":"OG001","value":"60","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"78","spread":null},{"groupId":"OG001","value":"105","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"76","spread":null},{"groupId":"OG001","value":"66","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"59","spread":null},{"groupId":"OG001","value":"87","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"81","spread":null},{"groupId":"OG001","value":"77","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"40","spread":null},{"groupId":"OG001","value":"69","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"76","spread":null},{"groupId":"OG001","value":"83","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"40","spread":null},{"groupId":"OG001","value":"58","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"95","spread":null},{"groupId":"OG001","value":"97","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"85","spread":null},{"groupId":"OG001","value":"93","spread":null}]}]}]},{"type":"SECONDARY","title":"Response Greater Than or Equal to 50 Percent Decrease From Baseline in Hamilton Depression Rating Scale (HAM-D 17) Total Score","description":"Participants with greater than or equal to 50 percent decrease from baseline in HAM-D 17 total score responded yes; others responded no. Total score is first 17 items of the HAM-D 25: measures range of depressive symptoms. Scale: 8 items 0-2 \\& 9 items 0-4, higher scores being more severe. Total possible score is 0 - 52. Endpoint is LOCF.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"72","spread":null},{"groupId":"OG001","value":"65","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"95","spread":null},{"groupId":"OG001","value":"112","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"85","spread":null},{"groupId":"OG001","value":"91","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"41","spread":null},{"groupId":"OG001","value":"59","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"95","spread":null},{"groupId":"OG001","value":"97","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73","spread":null},{"groupId":"OG001","value":"84","spread":null}]}]}]},{"type":"SECONDARY","title":"Remission as Measured by Montgomery Asberg Depression Scale (MADRS) Total Score Less Than or Equal to 12","description":"Remission response is yes if MADRS total score less than or equal to 12; if not, response is no. MADRS: 10-item instrument measuring depression; scale 0(Normal) \\& 6(most abnormal).Total possible score is 0 - 60. Endpoint is LOCF.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"41","spread":null},{"groupId":"OG001","value":"21","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"136","spread":null},{"groupId":"OG001","value":"168","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"54","spread":null},{"groupId":"OG001","value":"41","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"106","spread":null},{"groupId":"OG001","value":"135","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"70","spread":null},{"groupId":"OG001","value":"58","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"79","spread":null},{"groupId":"OG001","value":"105","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"66","spread":null},{"groupId":"OG001","value":"60","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"69","spread":null},{"groupId":"OG001","value":"93","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"70","spread":null},{"groupId":"OG001","value":"66","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"51","spread":null},{"groupId":"OG001","value":"80","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"70","spread":null},{"groupId":"OG001","value":"72","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"46","spread":null},{"groupId":"OG001","value":"69","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"87","spread":null},{"groupId":"OG001","value":"81","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"93","spread":null},{"groupId":"OG001","value":"109","spread":null}]}]}]},{"type":"SECONDARY","title":"Remission as Measured by Hamilton Asberg Depression Rating Scale (HAM-D 17) Total Score Less Than or Equal to 7","description":"Remission response is yes when HAM-D 17 total score is less than or equal to 7; if not, response is no. Total score is first 17 items of HAM-D 25, measures range of depressive symptoms. Scale: 8 items 0-2 and 9 items 0-4, higher scores more severe. Total possible score is 0 - 52. Endpoint is LOCF.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"32","spread":null},{"groupId":"OG001","value":"33","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"135","spread":null},{"groupId":"OG001","value":"144","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"56","spread":null},{"groupId":"OG001","value":"51","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"70","spread":null},{"groupId":"OG001","value":"99","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"59","spread":null},{"groupId":"OG001","value":"55","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"109","spread":null},{"groupId":"OG001","value":"126","spread":null}]}]}]},{"type":"PRIMARY","title":"Change in Montgomery-Asberg Depression Rating Scale (MADRS) Total Score","description":"Change is observed value at each visit minus baseline value. MADRS:10-item instrument measuring depression; scale range between 0(Normal) - 6(most abnormal)for each item. Total possible score is 0 - 60. Overall is average response Week 1 - Week 6.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.23","spread":"0.79"},{"groupId":"OG001","value":"-5.02","spread":"0.71"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-9.99","spread":"0.79"},{"groupId":"OG001","value":"-8.13","spread":"0.72"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-11.88","spread":"0.83"},{"groupId":"OG001","value":"-10.04","spread":"0.83"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-13.29","spread":"0.92"},{"groupId":"OG001","value":"-11.53","spread":"0.85"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-14.53","spread":"0.95"},{"groupId":"OG001","value":"-12.55","spread":"0.88"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-14.88","spread":"1.02"},{"groupId":"OG001","value":"-13.24","spread":"0.92"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-11.97","spread":"0.77"},{"groupId":"OG001","value":"-10.09","spread":"0.70"}]}]}]},{"type":"SECONDARY","title":"Change in Hamilton Depression Rating Scale (HAM-D 17) Total Score","description":"Change is observed value at each visit minus baseline value. HAM-D 17 Total score is first 17 items of HAM-D 25; measures range of depressive symptoms patient currently experiencing. Scale: 8 items 0-2 \\& 9 items 0-4; 0=absent or not depressed, 2 or 4=most severe or extreme. Total possible score is 0 - 52.Endpoint is LOCF","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-9.91","spread":"0.88"},{"groupId":"OG001","value":"-8.73","spread":"0.84"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-12.91","spread":"1.15"},{"groupId":"OG001","value":"-12.07","spread":"1.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.92","spread":"1.36"},{"groupId":"OG001","value":"-7.11","spread":"1.30"}]}]}]},{"type":"SECONDARY","title":"Change in Total Score in Hamiliton Depression Rating Scale (HAM-D 25)","description":"Change is observed value at each visit minus baseline value. HAM-D: 25-item instrument measuring the range of depressive symptoms patient currently experiencing. Scale: 14 items 0-2 \\& 11 items 0-4; 0=absent or not depressed, 2 or 4=most severe or extreme. Total possible score is 0 - 72. Endpoint is LOCF.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-11.68","spread":"1.07"},{"groupId":"OG001","value":"-10.76","spread":"1.02"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-15.48","spread":"1.32"},{"groupId":"OG001","value":"-14.80","spread":"1.22"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-8.06","spread":"1.64"},{"groupId":"OG001","value":"-8.58","spread":"1.56"}]}]}]},{"type":"SECONDARY","title":"Change in Bech Melancholia Score","description":"Change is observed value at each visit minus baseline value. Bech Melancholia is sum of scores on 6 Items pertaining to melancholia within HAM-D. Scale range 0 to 4; higher scores, greater severity. Total possible score is 0 - 24. Endpoint is LOCF.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.22","spread":"0.50"},{"groupId":"OG001","value":"-4.28","spread":"0.48"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.82","spread":"0.65"},{"groupId":"OG001","value":"-6.20","spread":"0.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.73","spread":"0.75"},{"groupId":"OG001","value":"-3.61","spread":"0.71"}]}]}]},{"type":"SECONDARY","title":"Change in Anxiety/Somatizations Factor Total Score","description":"Change is observed value at each visit minus baseline value. This test is sum of Scores on 6 Items pertaining to anxiety/somatization within HAM-D. Scale range 0 to 4 with higher scores reflecting greater severity. Total possible score is 0 - 24. Endpoint is LOCF.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.84","spread":"0.31"},{"groupId":"OG001","value":"-2.61","spread":"0.30"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.09","spread":"0.37"},{"groupId":"OG001","value":"-3.96","spread":"0.35"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.18","spread":"0.43"},{"groupId":"OG001","value":"-2.57","spread":"0.41"}]}]}]},{"type":"SECONDARY","title":"Change in Retardation Factor Scores","description":"Change is observed value at each visit minus baseline value. Retardation Factor is the sum of scores of 4 items which pertain to retardation within HAM-D. Scores 0 to 4, higher scores reflecting greater severity.Total possible score is 0 - 16. Endpoint is LOCF.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.22","spread":"0.35"},{"groupId":"OG001","value":"-2.68","spread":"0.34"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.38","spread":"0.45"},{"groupId":"OG001","value":"-3.66","spread":"0.42"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.24","spread":"0.50"},{"groupId":"OG001","value":"-1.88","spread":"0.48"}]}]}]},{"type":"SECONDARY","title":"Change in Sleep Disturbance Factor Score","description":"Change is observed value at each visit minus baseline value. Sleep Disturbance is the sum of scores of 3 items which pertain to sleep disturbance within Hamilton Depression Rating Scale (HAM-D). Scale range 0 to 4 with higher scores reflecting greater severity. Total possible score is 0 - 12.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.51","spread":"0.24"},{"groupId":"OG001","value":"-1.48","spread":"0.23"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.38","spread":"0.28"},{"groupId":"OG001","value":"-2.31","spread":"0.26"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.19","spread":"0.30"},{"groupId":"OG001","value":"-1.26","spread":"0.29"}]}]}]},{"type":"SECONDARY","title":"Change in Hamilton Anxiety Rating (HAM-A)","description":"Change is observed value at each visit minus baseline value. HAM-A:14-item scale to rate the intensity of psychic anxiety (items 1- 6, 14) and somatic anxiety (items 7-13) on a 5-point severity scale (0=not present to 4=very severe). Total possible score is 0 - 56.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.63","spread":"0.69"},{"groupId":"OG001","value":"-4.18","spread":"0.66"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.84","spread":"0.91"},{"groupId":"OG001","value":"-6.64","spread":"0.84"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.05","spread":"1.06"},{"groupId":"OG001","value":"-3.26","spread":"1.01"}]}]}]},{"type":"SECONDARY","title":"Change in Total Score of Young Mania Rating Scale (YMRS)","description":"Change is observed value at each visit minus baseline value. YMRS: 11 item instrument with scale range 0 to 4 for 7 items and 0 to 8 for 4 items. 0=normal; 4 or 8=most abnormal. Total possible score is 0 - 60. Overall is average response Week 1 - 6.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.40","spread":"0.36"},{"groupId":"OG001","value":"0.69","spread":"0.33"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.49","spread":"0.39"},{"groupId":"OG001","value":"-0.13","spread":"0.31"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.13","spread":"0.41"},{"groupId":"OG001","value":"0.00","spread":"0.34"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.60","spread":"0.36"},{"groupId":"OG001","value":"-0.77","spread":"0.31"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.94","spread":"0.35"},{"groupId":"OG001","value":"-0.77","spread":"0.31"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.45","spread":"0.43"},{"groupId":"OG001","value":"-0.66","spread":"0.37"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.20","spread":"0.32"},{"groupId":"OG001","value":"-0.27","spread":"0.26"}]}]}]},{"type":"SECONDARY","title":"Change in Global Clinical Severity of Symptoms (CGI-S)","description":"Change is observed value at each visit minus baseline value. CGI-S is an instrument to measure severity of mental illness. Scale range: 0 = not assessed, 1 = normal, 7 = among most extremely ill","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.39","spread":"0.08"},{"groupId":"OG001","value":"-0.25","spread":"0.07"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.66","spread":"0.08"},{"groupId":"OG001","value":"-0.51","spread":"0.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.88","spread":"0.10"},{"groupId":"OG001","value":"-0.84","spread":"0.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.03","spread":"0.11"},{"groupId":"OG001","value":"-0.98","spread":"0.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.27","spread":"0.11"},{"groupId":"OG001","value":"-1.15","spread":"0.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.34","spread":"0.11"},{"groupId":"OG001","value":"-1.28","spread":"0.11"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.93","spread":"0.08"},{"groupId":"OG001","value":"-0.84","spread":"0.08"}]}]}]},{"type":"SECONDARY","title":"Change in Global Clinical Improvement of Symptoms (CGI -I)","description":"Change is observed value at each visit minus baseline value. CGI-I is an instrument for Global assessment of improvement in patient's condition. Scale range:0=not assessed, 1=very much improved, 7=very much worse","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.37","spread":"0.10"},{"groupId":"OG001","value":"3.61","spread":"0.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.09","spread":"0.11"},{"groupId":"OG001","value":"3.29","spread":"0.11"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.89","spread":"0.12"},{"groupId":"OG001","value":"3.04","spread":"0.11"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.74","spread":"0.12"},{"groupId":"OG001","value":"2.94","spread":"0.11"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.61","spread":"0.13"},{"groupId":"OG001","value":"2.84","spread":"0.12"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.52","spread":"0.13"},{"groupId":"OG001","value":"2.64","spread":"0.12"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.87","spread":"0.10"},{"groupId":"OG001","value":"3.06","spread":"0.10"}]}]}]},{"type":"SECONDARY","title":"Change in Global Assessment of Functioning (GAF)","description":"Change is observed value at each visit minus baseline value. GAF is an instrument used to assess global psychological, social, \\& occupational functioning. Scale range: 100 = normal and 0 = greatest abnormality.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.59","spread":"1.52"},{"groupId":"OG001","value":"9.53","spread":"1.42"}]}]}]},{"type":"SECONDARY","title":"Change in Quality of Life, Enjoyment, and Satisfaction Scale (Q-LES-Q) Total Score","description":"Change is observed value at each visit minus baseline value. Q-LES-Q: 16- item instrument for a patient's assessment of his/her quality of life. Scale range: overall level of satisfaction 1=very poor to 5=Very good. 1 item (medication)can be left blank. Total possible score 15 - 80.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.06","spread":"0.02"},{"groupId":"OG001","value":"0.06","spread":"0.01"}]}]}]},{"type":"SECONDARY","title":"Change in Sheehan Disability Scale (SDS) Total Score","description":"Change is observed value at each visit minus baseline value. SDS is a patient rated measure of disability and impairment in work/school, social life, family life/home responsibilities. Scale range: 0-10 with 0=no disruption,10=extreme disruption. Total possible score is 0 - 30.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.69","spread":"0.93"},{"groupId":"OG001","value":"-3.05","spread":"0.91"}]}]}]},{"type":"SECONDARY","title":"Change in Bipolar Cognition Rating Scale (BPCoRS) Interviewer Global Rating of Subject","description":"Change is observed value at each visit minus baseline value. BPCoRs: Subject interview with 20-items measuring cognitive deficits \\& degree of affect on functioning. Scale range:0 to 4, higher numbers, greater impairment. Total possible score is 0 - 80. Endpoint=last observation carried forward (LOCF)","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.65","spread":"0.24"},{"groupId":"OG001","value":"-0.73","spread":"0.22"}]}]}]},{"type":"SECONDARY","title":"Change in Bipolar Cognition Rating Scale (BPCoRS) Informant Global Rating","description":"Change is observed value at each visit minus baseline value. Informant Global Rating is interview with informant of subject using BPCoRS, a 20-item instrument measuring cognitive deficits \\& degree of affect on functioning. Scale: 0 to 4, higher numbers = greater impairment. Total possible score is 0 - 80. Endpoint is LOCF.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.66","spread":"0.21"},{"groupId":"OG001","value":"4.68","spread":"0.21"}]}]}]},{"type":"SECONDARY","title":"Change in Bipolar Cognition Rating Scale (BPCoRS) Global Rating by Interviewer","description":"Change in Rating by interviewer, using BPCoRS, 20-item instrument measuring cognitive deficits and the degree of affect on functioning; 4 point scale with higher numbers reflecting greater impairment.Total possible score is 0 - 80.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.72","spread":"0.18"},{"groupId":"OG001","value":"4.63","spread":"0.17"}]}]}]},{"type":"SECONDARY","title":"Change in Bipolar Cognition Rating Scale (BPCoRS) Subject Rating at Endpoint","description":"Change is observed value at each visit minus baseline value. Subject Rating: Subject's perceived change in status using a 20-item instrument measuring cognitive deficits and degree of affect on funtioning. Scale 0 to 4, higher numbers reflecting greater impairment. Total possible score is 0 - 80. Endpoint is last observation carried forward.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.69","spread":"0.19"},{"groupId":"OG001","value":"4.81","spread":"0.17"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":3},"commonTop":["Headache","Nausea","Somnolence","Sedation","Diarrhoea"]}}}